English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/164733
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics

AutorMcKerrell, Thomas; Moreno, Thaidy; Varela, Ignacio ; Vassiliou, George S.
Fecha de publicación2017
EditorAmerican Society of Hematology
CitaciónBlood Advances 1(14): 968-971 (2017)
ResumenThe JAK2 V617F mutation is the most common somatic mutation in the classical myeloproliferative neoplasms (MPNs), present in >95% of cases of polycythemia vera (PV) and ~50% of essential thrombocythemia (ET) and myelofibrosis (MF).1-4 It is usually the sole identifiable driver mutation in MPNs5 and was recently also identified as a driver of age-related clonal hemopoiesis in healthy individuals.6-9 In order to investigate the preclinical clonal evolution of MPNs, we identified 12 individuals with a JAK2 V617F mutant MPN, who 4.6 to 15.2 years previously (median 10.2 years) had also donated blood to register with the Cyprus Bone Marrow Donor Registry at the Karaiskakio Foundation
DescripciónMcKerrell, Thomas et al.
Versión del editorhttps://doi.org/10.1182/bloodadvances.2017007047
URIhttp://hdl.handle.net/10261/164733
Identificadoresdoi: 10.1182/bloodadvances.2017007047
e-issn: 2473-9529
Aparece en las colecciones: (IBBTEC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
JAkinetics.pdf789,55 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.